FDA
approval
· 2023-06-01
FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (NorthStar RxLLC)
Summary
The FDA approved the original application for a generic fixed-dose combination of olmesartan medoxomil and hydrochlorothiazide. This enables NorthStar RxLLC to …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)